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Patients who are not in significant respiratory failure may also 
require aerosol-generating procedures (AGPs), such as chest 
physiotherapy or pulmonary function tests, for management of 
other conditions. Preventing healthcare-associated transmission 
of infection requires understanding both how SARS-CoV-2 is 
spread, as well as the specific risks associated with commonly-
used respiratory procedures. This document summarizes current 
understanding of these issues. 
Respiratory Particle Definitions
Respiratory Droplets: Particles consisting mostly of water 
that are large enough to settle rapidly on a surface after being 
produced. There is no universally-accepted size cut off, but 
droplets are often defined as being > 5μm in diameter. Droplets 
are dispersed over shorter distances and remain in the air for 
shorter periods of time than aerosols.
Respiratory Aerosols: Smaller particles (usually <5μm) that 
can remain suspended in the air for minutes to hours. This term is 
sometimes used interchangeably with “droplet nuclei.” Aerosols 
can disperse over long distances and spread via ventilation 
systems. Aerosols can be generated by sneezing, coughing, 
speaking, singing, and laughing.
Mechanisms of Viral Transmission
Table 1 summarizes possible routes of respiratory virus 
transmission.
SARS-CoV-2 Transmission
Determining viral transmission dynamics is complex and difficult 
to investigate experimentally. Previous research on coronaviruses, 
including the viruses that cause Severe Acute Respiratory 
Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), 
suggest that contact and droplet transmission are very likely, and 
that aerosol transmission may also be possible.2 Early research 
on SARS-CoV-2 has shown that the virus can remain infectious 
on certain surfaces for up to 72 hours and in aerosols for up to 3 
hours.3 This suggests that the virus may spread through contact, 
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The novel coronavirus SARS-CoV-2 was identified in China in 
December 2019. With evidence of global spread, it has become a 
pandemic. At the time of writing, COVID-19, the clinical syndrome 
caused by SARS-CoV-2, has claimed over 340,653 lives and 
stretched the capacity of healthcare systems around the world.1 
The hallmark of severe COVID-19 is hypoxemic respiratory failure. 
Management of this condition historically involves procedures that 
have the potential to generate respiratory aerosols such as  
non-invasive ventilation and endotracheal intubation.
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Table 1. Routes of Respiratory Virus Transmission.2
Type of Transmission Mechanism Comments Example
Direct  
contact
Infective particles are transferred 
directly from infected person to 
susceptible host.
John is infected and shakes hands 
with Mary, directly transferring infective 
particles to her hand.
Indirect  
contact
Infective particles are transferred from 
an infected person to a susceptible 
host via an environmental surface.
Duration of infectivity varies based on type 
of virus, type of surface, and environmental 
factors such as temperature and humidity.
John coughs on his hand and touches 
a door-knob. Mary opens the door and 
then touches her face with her now-
contaminated hand.
Droplet Infective droplets settle on the 
mucosa (respiratory tract or eyes) of 
a susceptible host.
Requires close contact with infected individual. 
Because of their larger size, particles generally 
deposited in upper respiratory tract..
John laughs while talking to Mary. She 
inhales infective droplets.
Aerosol Infective aerosols settle on the 
mucosa (respiratory tract or eyes) of 
a susceptible host.
No close contact required. Because of their 
small size, particles can settle throughout 
the respiratory tract, including in the lower 
airways.
John coughs, generating infective 
aerosols that remain suspended in the 
air. Mary enters the room 30 minutes 
later and inhales the aerosols
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droplet, AND aerosol transmission. This potential for multimodal 
transmission is reflected in the current CDC recommendations 
requiring healthcare professionals wear N95 respirators (where 
available) when caring for all patients with confirmed or suspected 
COVID-19.4 The World Health Organization continues to 
recommend respirators only for healthcare workers performing 
aerosol-generating procedures, as they feel airborne transmission 
of the virus is likely limited to this context.5 
 Aerosol Generating Procedures and Risks of SARS-CoV-2 
Transmission
Aerosol generating procedures (AGPs) are those that have the 
potential to generate aerosols and droplets that can spread 
respiratory pathogens (Table 2). However, much of the information 
regarding the true aerosolizing potential of various procedures, 
and their role in the transmission of respiratory diseases is 
speculative.6 Most data regarding risks to healthcare workers 
has been extrapolated from epidemiologic data collected during 
infectious outbreaks. For example, case-control and retrospective 
cohort studies during the SARS outbreak show increased risk 
of transmission associated with endotracheal intubation, and 
possibly non-invasive ventilation and tracheostomy. No increased 
risk was seen with 20 other AGPs.6 However, these studies are 
limited by sample size and study design. 
Table 2: Procedures with potential to generate respiratory aerosols
 ■ Non-invasive ventilation 
(examples)
 ❍ Bi-level
 ❍ CPAP/Autopap
 ❍ ASV
 ❍ Home ventilators
 ■ Sputum induction
 ■ Chest physiotherapy 
 ■ High flow oxygen
 ■ Nebulizer administration
 ■ Bronchoscopy
 ■ Airway suctioning
 ■ Pulmonary function testing
 ■ Bag mask ventilation prior  
to intubation
 ■ Endotracheal intubation  
and extubation
 ■ High frequency oscillatory 
ventilation
 ■ Tracheostomy
 ■ Speech language pathologists’ 
procedures (instrumental and 
non-instrumental) that trigger 
cough reflex
 ■ E.N.T procedures that trigger 
cough refle
 ■ Surgery
 ■ Autopsy
 ■ Cardiopulmonary resuscitation
CPAP = continuous positive airway pressure; ASV = adaptive servo ventilation.
Reducing Risks of Transmission During Aerosol Generating 
Procedures
Given the uncertainty around the transmission risks associated 
with AGPs, many institutions and professional societies 
recommend postponing non-urgent AGPs (e.g. pulmonary 
functions tests for monitoring of chronic lung disease), and 
optimizing the patient environment and using maximal protective 
equipment when AGPs are required. In addition to employing 
standard and droplet precautions, the following may be used:
N95 Respirators: N95s are masks that (when fitted properly) 
block at least 95% of 0.3 micron particles. The CDC and the WHO 
recommend the use of N95 respirators during any AGP. 
N100 Respirators: N100s are masks that (when fitted properly) 
block at least 99.97% of 0.3 micron particles. 
Powered Air Purifying Respirators (PAPR): PAPRs are half or 
full face masks connected to a breathing tube, battery-operated 
blower, and a particulate filter. Room air is blown through the filter 
and thus purified before being delivered to the facepiece. 
Face Shields: Face shields are clear plastic barriers that cover 
the face and block portals of entry. They are typically worn in 
conjunction with face masks and may further reduce transmission 
of droplets and aerosols containing virus.8
Protective Eyewear: Transmission of the virus through ocular 
route has been described and therefore eyes should be shielded at 
all times during these procedures.9
Negative Pressure Rooms: Negative pressure rooms are those 
in which the air pressure is maintained at a lower level than that 
of surrounding patient care areas. As a result, air flow is directed 
into the negative pressure room, preventing aerosols from 
moving into higher pressure areas. The contaminated air is then 
ventilated out of patient care areas. Per CDC standards, negative 
pressure rooms must have a minimum of 12 air changes per hour.10 
Performing AGPs in negative pressure rooms reduces the risk of 
aerosol spread to other patient care areas. It DOES NOT obviate the 
need for healthcare providers engaged in AGPs to wear appropriate 
respirators. 
Conclusion
Our understanding of SARS-CoV-2 continues to evolve. Mounting 
evidence suggests the virus can be transmitted via contact, 
droplet, and possibly aerosol routes. Management of patients with 
COVID-19 often requires AGPs. Healthcare workers performing 
AGPs should use appropriate personal protective equipment 
(minimum of N95 respirator as well as standard and droplet 
precautions). Where possible, AGPs should be performed in 
negative pressure rooms to minimize risk of viral transmission to 
other patient care areas.
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